Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honghui Zhou

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Journal of Clinical Pharmacology|February 6, 2010
Lack of racial differences in the pharmacokinetics of subcutaneous golimumab in healthy Japanese and Caucasian male subjectsJie Ling, Sally Lyn, Zhenhua Xu, et al.
Prenatal Diagnosis|June 6, 2021
Combined exome sequencing and deep phenotyping in highly selected fetuses with skeletal dysplasia during the first and second trimesters improves diagnostic yieldXinyue Zhang, Yuan Ren, Rui Song, et al.
Clinical Pharmacokinetics|September 4, 2009
Pharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjectsJuan José Pérez-Ruixo, Wojciech Krzyzanski, Esther Bouman-Thio, et al.
American Journal of Respiratory and Critical Care Medicine|December 13, 2005
Titin and diaphragm dysfunction in chronic obstructive pulmonary diseaseCoen A C Ottenheijm, Leo M A Heunks, Theo Hafmans, et al.
Journal of Crohn'S & Colitis|July 22, 2016
Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance StudiesOmoniyi J Adedokun, Zhenhua Xu, Colleen W Marano, et al.
Stem Cell Research & Therapy|June 19, 2026
Efficacy and safety of allogeneic umbilical cord blood mononuclear cells therapy in children with autism spectrum disorder and immune dysregulation: a single-center, double-blinded, randomized, placebo-controlled trialZiyan Zhang, Guanglei Wang, Fang Han, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjectsYanli Zhuang, Zhenhua Xu, Dick E de Vries, et al.
Journal of Clinical Pharmacology|July 24, 2013
Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time dataGerald J Fetterly, Urvi Aras, Patricia D Meholick, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 28, 2012
A new class of room-temperature multiferroic thin films with bismuth-based supercell structureAiping Chen, Honghui Zhou, Zhenxing Bi, et al.
British Journal of Clinical Pharmacology|December 9, 2022
Population pharmacokinetics and exposure-response analyses of daratumumab plus pomalidomide/dexamethasone in relapsed or refractory multiple myelomaAnne-Gaelle Dosne, Xia Li, Man Melody Luo, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Journal of Clinical Pharmacology|February 6, 2010
Lack of racial differences in the pharmacokinetics of subcutaneous golimumab in healthy Japanese and Caucasian male subjectsJie Ling, Sally Lyn, Zhenhua Xu, et al.
Prenatal Diagnosis|June 6, 2021
Combined exome sequencing and deep phenotyping in highly selected fetuses with skeletal dysplasia during the first and second trimesters improves diagnostic yieldXinyue Zhang, Yuan Ren, Rui Song, et al.
Clinical Pharmacokinetics|September 4, 2009
Pharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjectsJuan José Pérez-Ruixo, Wojciech Krzyzanski, Esther Bouman-Thio, et al.
American Journal of Respiratory and Critical Care Medicine|December 13, 2005
Titin and diaphragm dysfunction in chronic obstructive pulmonary diseaseCoen A C Ottenheijm, Leo M A Heunks, Theo Hafmans, et al.
Journal of Crohn'S & Colitis|July 22, 2016
Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance StudiesOmoniyi J Adedokun, Zhenhua Xu, Colleen W Marano, et al.
Stem Cell Research & Therapy|June 19, 2026
Efficacy and safety of allogeneic umbilical cord blood mononuclear cells therapy in children with autism spectrum disorder and immune dysregulation: a single-center, double-blinded, randomized, placebo-controlled trialZiyan Zhang, Guanglei Wang, Fang Han, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjectsYanli Zhuang, Zhenhua Xu, Dick E de Vries, et al.
Journal of Clinical Pharmacology|July 24, 2013
Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time dataGerald J Fetterly, Urvi Aras, Patricia D Meholick, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 28, 2012
A new class of room-temperature multiferroic thin films with bismuth-based supercell structureAiping Chen, Honghui Zhou, Zhenxing Bi, et al.
British Journal of Clinical Pharmacology|December 9, 2022
Population pharmacokinetics and exposure-response analyses of daratumumab plus pomalidomide/dexamethasone in relapsed or refractory multiple myelomaAnne-Gaelle Dosne, Xia Li, Man Melody Luo, et al.
Pageof 15